Cadaveric Study on the Safety of High‐Flow Nasal Oxygen in Laser Microlaryngeal Surgery
The Laryngoscope · 2024
DOI: 10.1002/lary.31733 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Ellen L Ferraro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Division of Laryngology, University of Rochester Medical Center, Rochester, New York, U.S.A. Hauptthemen laut MEDLINE: Cadaver, Laser Therapy, Oxygen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
High‐flow nasal oxygen (HFNO), or transnasal humidified rapid‐insufflation ventilatory exchange (THRIVE), is a technique providing apneic oxygenation and a degree of ventilation during microlaryngeal surgery. Its use with laser has been questioned due to concern for airway fire. For fire to occur, a triad of ignition source, oxidizer, and fuel source must be present. By using HFNO and eliminating an endotracheal tube (fuel source), it is hypothesized that airway fire risk is minimal. We tested this theory with human cadavers using HFNO with increasing levels of FiO 2 while performing microlaryngeal laser surgery.
Methods
HFNO was placed on two cadavers, and oxygen was administered at incrementally increasing fraction of inspired oxygen (FiO 2 ) concentrations (30%–100%). Laryngeal microsurgery was conducted with CO 2 and KTP lasers applied for 30 s. Oxygen readings were taken at several anatomic locations along the body assessing oxygen concentrations in correlation with increasing FiO 2 administration.
Results
The use of CO 2 and KTP laser on cadaveric vocal folds produced char but no spark or airway fire at any of the tested oxygen concentrations. Apart from the mouth, there was minimal increase in oxygen levels at the surrounding anatomic sites despite elevating FiO 2 levels.
Conclusion
HFNO may be safe to use during microlaryngeal laser surgery. By eliminating the endotracheal tube as a fuel source, risk of airway fire may be negligible. Our study safely applied CO 2 and KTP lasers for an uninterrupted 30 s with HFNO at 70 L/min and 100% FiO 2 producing no spark or fire. Level of Evidence NA Laryngoscope , 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Division of Laryngology, University of Rochester Medical Center, Rochester, New York, U.S.A.
- Department of Otolaryngology, Division of Laryngology, Wayne State School of Medicine, Detroit, Michigan, U.S.A.
- Department of Otolaryngology, Division of Laryngology, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of Otolaryngology, Division of Laryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
ORCID-Profile: Ellen L Ferraro, Michael S Benninger, Paul C Bryson
Zitieren
APA
Ferraro, E. L., Zura, N., Abdelmalak, B. B., Galway, U., Benninger, M. S., & Bryson, P. C. (2024). Cadaveric Study on the Safety of High‐Flow Nasal Oxygen in Laser Microlaryngeal Surgery. The Laryngoscope. https://doi.org/10.1002/lary.31733
Vancouver
Ferraro EL, Zura N, Abdelmalak BB, Galway U, Benninger MS, Bryson PC. Cadaveric Study on the Safety of High‐Flow Nasal Oxygen in Laser Microlaryngeal Surgery. The Laryngoscope. 2024. doi:10.1002/lary.31733
BibTeX
@article{Ferraro2024,
author = {Ferraro, Ellen L and Zura, Nicholas and Abdelmalak, Basem B and Galway, Ursula and Benninger, Michael S and Bryson, Paul C},
title = {Cadaveric Study on the Safety of High‐Flow Nasal Oxygen in Laser Microlaryngeal Surgery},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31733}
}
EUVIMED